Listed
1997-10
First close
EUR 0.1870
split-adjusted
Since listing
+46884%
13 points—
Current
EUR 87.84
$17.2 B · 2026-11-12 13:05 CET
Peak
EUR 88.00
$17.2 B2026-11
Low
EUR 87.76
$17.2 B2026-11
Latest change
-0.2%
Prior close → 13:05
Change since first
-0.2%
2026-11
52-week range
EUR 54.86 – EUR 89.28
Drawdown
-1.6%
Avg vol 3m
316K
Dividend yield
0.82%
Price history
Nov 12, 2026
Monthly closes from Yahoo Finance, split-adjusted, dividends excluded. Earlier points are actual closes, not reconstructed.
Time (CET)CloseMarket capChange
- 13:05EUR 87.84$17.2 B-0.2%
- 13:00EUR 87.88$17.2 B-0.1%
- 12:55EUR 87.90$17.2 B-0.1%
- 12:50EUR 87.88$17.2 B-0.1%
- 12:45EUR 87.84$17.2 B-0.2%
- 12:40EUR 87.84$17.2 B-0.2%
- 12:35EUR 87.82$17.2 B-0.2%
- 12:30EUR 87.86$17.2 B-0.2%
- 12:25EUR 87.86$17.2 B-0.2%
- 12:20EUR 87.86$17.2 B-0.2%
- 12:15EUR 87.82$17.2 B-0.2%
- 12:10EUR 87.76$17.2 B-0.3%
- 09:00EUR 88.00$17.2 B0.0%
Ownership & Control
Shareholding as of 2026-06-30- Controlling entity
- Analytical Bioventures SCA (Martin family) — 36.5%
- Insiders
- 36.55%
- Institutions
- 35.73%(360 holders)
- Free float
- 56.31%
Percentages are of total shares outstanding, aggregated from 13F-style filings via Yahoo Finance. Institutional figures reflect US-filed positions and may undercount owners filing elsewhere. No figure is shown where none is disclosed.
In the press
All coverage →- Eurofins delivers improving organic growth through 9M 2026, remains on track for 2026 and mid-term profitability objectives2026-10-21
- Eurofins completes the acquisition of Element Materials Technology's life sciences testing services business in North America2026-10-02
- Eurofins First Half Year 2026 Report: 130bps Adjusted EBITDA Margin Expansion and 29% Basic EPS Growth2026-07-23